FI960367A - Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia - Google Patents

Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia Download PDF

Info

Publication number
FI960367A
FI960367A FI960367A FI960367A FI960367A FI 960367 A FI960367 A FI 960367A FI 960367 A FI960367 A FI 960367A FI 960367 A FI960367 A FI 960367A FI 960367 A FI960367 A FI 960367A
Authority
FI
Finland
Prior art keywords
dialkoxypyridinylbenzimidazole
derivatives
new
new dialkoxypyridinylbenzimidazole
dialkoxypyridinylbenzimidazole derivatives
Prior art date
Application number
FI960367A
Other languages
English (en)
Swedish (sv)
Other versions
FI960367A0 (fi
Inventor
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Unge Pet Oskar Sverker Von
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI960367A0 publication Critical patent/FI960367A0/fi
Publication of FI960367A publication Critical patent/FI960367A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI960367A 1994-05-27 1996-01-26 Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia FI960367A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (2)

Publication Number Publication Date
FI960367A0 FI960367A0 (fi) 1996-01-26
FI960367A true FI960367A (fi) 1996-01-26

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960367A FI960367A (fi) 1994-05-27 1996-01-26 Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia

Country Status (18)

Country Link
EP (1) EP0712401A1 (fi)
JP (1) JPH09504557A (fi)
CN (1) CN1128997A (fi)
AU (1) AU2633095A (fi)
BR (1) BR9506235A (fi)
CA (1) CA2166988A1 (fi)
CZ (1) CZ24396A3 (fi)
EE (1) EE9600011A (fi)
FI (1) FI960367A (fi)
HU (1) HU9600005D0 (fi)
IL (1) IL113604A0 (fi)
IS (1) IS4321A (fi)
MA (1) MA23563A1 (fi)
NO (1) NO960268L (fi)
PL (1) PL312692A1 (fi)
TN (1) TNSN95062A1 (fi)
WO (1) WO1995032959A1 (fi)
ZA (1) ZA954125B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100619200B1 (ko) 1998-11-18 2006-09-05 아스트라제네카 아베 개선된 화학적 제조 방법 및 제약 제형
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP2086543A2 (en) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2009105568A1 (en) 2008-02-20 2009-08-27 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184602T1 (de) * 1990-06-20 1999-10-15 Astra Ab Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung

Also Published As

Publication number Publication date
HU9600005D0 (en) 1996-03-28
EP0712401A1 (en) 1996-05-22
IL113604A0 (en) 1995-08-31
NO960268D0 (no) 1996-01-23
CN1128997A (zh) 1996-08-14
TNSN95062A1 (fr) 1996-02-06
AU2633095A (en) 1995-12-21
EE9600011A (et) 1996-04-15
JPH09504557A (ja) 1997-05-06
WO1995032959A1 (en) 1995-12-07
FI960367A0 (fi) 1996-01-26
CA2166988A1 (en) 1995-12-07
BR9506235A (pt) 1997-08-12
NO960268L (no) 1996-01-23
MA23563A1 (fr) 1995-12-31
ZA954125B (en) 1995-11-27
IS4321A (is) 1996-01-17
PL312692A1 (en) 1996-05-13
CZ24396A3 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
DE69735712D1 (de) Aryl-pyrimidin-derivate
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
FI955927A0 (fi) Substituoidut 1H-imidatsolit
EE9800219A (xx) Uued 19-nor-pregneeni derivaadid
NO981946D0 (no) Imidazoquinazolin-derivater
DE69534718D1 (de) Substituierte 9-alkyladenine
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DE69430587T2 (de) Pyrimidin-acyclonukleosid-derivate
BR9509793A (pt) Derivados de tiofeneno
IS4321A (is) Nýjar díalkoxý-pýridínýl-bensimidasólafleiður
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
DE69527786D1 (de) Diaminomethyliden-derivate
NO965233D0 (no) Deacetoksytaksol-derivat
DE69521745T2 (de) Diazacycloalkanalkylsulfonamid-derivat
DE59509209D1 (de) Diphenyloxazolin-derivate
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
BR9509559A (pt) Azolilulsolfonilfeniluracilas substituídas
DE69510792T2 (de) Naphtochinonderivate
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
BR9506613A (pt) Derivados de feniltio-oxazolinas
DE59510274D1 (de) Substituierte biphenyloxazoline
BR9508450A (pt) Derivados de n-alcóxi-amidina
NO951573D0 (no) Tiadiazinon-derivater

Legal Events

Date Code Title Description
FD Application lapsed